Omalizumab effectiveness in patients with a previously failed oral immunotherapy for severe milk allergy

BACKGROUND: Some studies addressed the issue of omalizumab (OML) effectiveness in children starting their first oral immunotherapy (OIT) attempt but no study investigated the possible role of OML in the setting of patients with persisting milk allergy after a failed OIT attempt. METHODS: Single‐cent...

Descripción completa

Detalles Bibliográficos
Autores principales: Badina, Laura, Belluzzi, Beatrice, Contorno, Sarah, Bossini, Benedetta, Benelli, Elisa, Barbi, Egidio, Berti, Irene
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Short Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8669684/
https://www.ncbi.nlm.nih.gov/pubmed/34623772
http://dx.doi.org/10.1002/iid3.542

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8669684/
https://www.ncbi.nlm.nih.gov/pubmed/34623772
http://dx.doi.org/10.1002/iid3.542

Ejemplares similares